Which of the following is an appropriate dose for erenumab (Aimovig®) for migraine prevention?
1) 675 mg subcutaneously every 3 months
2) 70 mg orally every other day
3) 240 mg subcutaneously once monthly
4) 140 mg subcutaneously once monthly